All Comments by Richard C. Mohs
Go to another page:
- 1
- 2
- John Trojanowski, 75, a Giant in the Field of Neuropathology
- Peter Davies, Beloved Giant of Alzheimer’s Disease Research, Dies at 72
- What Lies Beneath: Intracranial Probes Pick Up Hippocampal Seizures in AD
- Next Up for Human Brain Imaging: Synaptic Density?
- Plasma beta-amyloid 1-40 is associated with the diffuse small vessel disease subtype.
- Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.
- Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels.
- Familial Alzheimer's Disease Mutations in Presenilin 1 Do Not Alter Levels of the Secreted Amyloid-beta Protein Precursor Generated by beta-Secretase Cleavage.
- Assessing the relationship between health utilities, quality of life, and health care costs in Alzheimer's disease: the CATIE-AD study.
- Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration.
- Burden of Alzheimer's disease and association with negative health outcomes.
- Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.
- Safety of lumbar puncture procedures in patients with Alzheimer's disease.
- Age, neuropathology, and dementia.
- Amyloid imaging in mild cognitive impairment subtypes.